Table 1.
Patient characteristics; median values are shown in parentheses
| n = 89 | |||
|---|---|---|---|
| Age | 31–88 (62) | ||
| Pathology | |||
| SCC | 82 | ||
| ASC | 2 | ||
| AC | 5 | ||
| FIGO stage (2008) | |||
| Ia | 1 | ||
| Ib1 | 5 | ||
| Ib2 | 1 | ||
| IIa | 2 | ||
| IIb | 35 | ||
| IIIa | 3 | ||
| IIIb | 35 | ||
| IVa | 7 | ||
| Pelvic lymph node metastasis | |||
| No | 32 | ||
| Yes | 57 | ||
| Pretreatment tumor diameter (cm) | 1.5–11 (5.2) | ||
| Pretreatment tumor volume (cc) | 10.0–247.8 (60.2) | ||
| Measured by MR | 76 | ||
| CT | 13 | ||
| Pretreatment hemoglobin level (g/dl) | 6.2–15.4 (11.7) | ||
| Pretreatment SCC antigen level (ng/ml) | 0.8–194.0 (6.9) |
SCC = Squamous cell carcinoma, ASC = adenosquamous cell carcinoma, AC = adenocarcinoma.